Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Will Vanguard Growth Keep Crushing Its ETF Peers?


Exchange-traded fund investors are always on the lookout for funds that can generate long-term outperformance. With so many different types of ETFs to choose from, there's no shortage of ideas for investors to pursue to seek out market-beating gains. And because it's relatively easy to set up a new ETF, you can typically find plenty of funds out there addressing hot ideas that tie into the areas of the market that are doing the best at any given time.

Growth investing has been highly successful since the financial crisis, and Vanguard Growth ETF (NYSEMKT: VUG) has taken full advantage, outperforming the market over long periods of time. However, the jury is still out on whether growth stock investing will continue to generate similar returns to what it has in the recent past. In this final article on the Vanguard Growth ETF for the Voyager Portfolio, you'll find out more about the debate within the investing community and what the future could hold for the fund.

Image source: Getty Images.

Continue reading


Source Fool.com

Voyager Therapeutics Inc Stock

€3.51
3.980%
Voyager Therapeutics Inc dominated the market today, gaining €0.13 (3.980%).

Like: 0
VUG
Share

Comments